Astrana Health Zukünftiges Wachstum
Future Kriterienprüfungen 3/6
Astrana Health wird ein Gewinn- und Umsatzwachstum von 16.7% bzw. 12.9% pro Jahr prognostiziert, während der Gewinn pro Aktie um 15% pro Jahr wachsen soll.
Wichtige Informationen
18.0%
Wachstumsrate der Gewinne
16.5%
EPS-Wachstumsrate
| Healthcare Gewinnwachstum | 19.0% |
| Wachstumsrate der Einnahmen | 15.7% |
| Zukünftige Eigenkapitalrendite | n/a |
| Analystenabdeckung | Good |
| Zuletzt aktualisiert | 26 Jul 2024 |
Jüngste Aktualisierungen zum künftigen Wachstum
Recent updates
Is There Now An Opportunity In Astrana Health, Inc. (NASDAQ:ASTH)?
Jun 19
Capital Allocation Trends At Astrana Health (NASDAQ:ASTH) Aren't Ideal
Jun 02Astrana Health, Inc. (NASDAQ:ASTH) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
May 09Investors Still Waiting For A Pull Back In Astrana Health, Inc. (NASDAQ:ASTH)
Apr 15At US$40.82, Is Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Worth Looking At Closely?
Feb 25Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Feb 07Apollo Medical Holdings: Good Company, Not Quite A Hold
Jan 17With Apollo Medical Holdings, Inc. (NASDAQ:AMEH) It Looks Like You'll Get What You Pay For
Dec 27Returns On Capital At Apollo Medical Holdings (NASDAQ:AMEH) Have Stalled
Nov 08Should You Investigate Apollo Medical Holdings, Inc. (NASDAQ:AMEH) At US$30.62?
Oct 26Apollo Medical Holdings (NASDAQ:AMEH) Has A Pretty Healthy Balance Sheet
Sep 22Returns At Apollo Medical Holdings (NASDAQ:AMEH) Appear To Be Weighed Down
Aug 04A Look At The Intrinsic Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Jul 19We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Stay On Top Of Its Debt
Jun 19Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 05Does This Valuation Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH) Imply Investors Are Overpaying?
Apr 20Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Mar 21Apollo Medical Holdings (NASDAQ:AMEH) Has More To Do To Multiply In Value Going Forward
Jan 06Is Apollo Medical Holdings (NASDAQ:AMEH) Using Too Much Debt?
Dec 16Apollo Medical to acquire Valley Oaks Medical Group
Oct 05Apollo Medical to acquire a San Francisco Bay area physicians' group, health plan
Sep 26A Look At The Fair Value Of Apollo Medical Holdings, Inc. (NASDAQ:AMEH)
Sep 21The Return Trends At Apollo Medical Holdings (NASDAQ:AMEH) Look Promising
Sep 06With EPS Growth And More, Apollo Medical Holdings (NASDAQ:AMEH) Makes An Interesting Case
Aug 22Apollo Medical Q2 GAAP EPS beats estimate, co reiterates FY 2022 revenue guidance
Aug 04Is Apollo Medical Holdings (NASDAQ:AMEH) A Risky Investment?
Aug 04Apollo Medical Holdings' (NASDAQ:AMEH) Returns On Capital Are Heading Higher
May 17We Think Apollo Medical Holdings (NASDAQ:AMEH) Can Manage Its Debt With Ease
May 02Gewinn- und Umsatzwachstumsprognosen
| Datum | Umsatz | Gewinne | Freier Cashflow | Bargeld aus operativen Tätigkeiten | Durchschn. Anz. Analysten |
|---|---|---|---|---|---|
| 12/31/2026 | 2,571 | 99 | N/A | 128 | 2 |
| 12/31/2025 | 2,156 | 85 | 101 | 118 | 8 |
| 12/31/2024 | 1,763 | 70 | 78 | 82 | 8 |
| 3/31/2024 | 1,454 | 62 | 52 | 66 | N/A |
| 12/31/2023 | 1,387 | 61 | 40 | 68 | N/A |
| 9/30/2023 | 1,328 | 45 | 112 | 134 | N/A |
| 6/30/2023 | 1,297 | 46 | 61 | 83 | N/A |
| 3/31/2023 | 1,218 | 45 | 46 | 66 | N/A |
| 12/31/2022 | 1,144 | 45 | 59 | 82 | N/A |
| 9/30/2022 | 1,045 | 58 | -40 | -15 | N/A |
| 6/30/2022 | 955 | 69 | 41 | 72 | N/A |
| 3/31/2022 | 861 | 70 | 48 | 84 | N/A |
| 12/31/2021 | 774 | 69 | 51 | 70 | N/A |
| 9/30/2021 | 756 | 70 | 63 | 80 | N/A |
| 6/30/2021 | 709 | 53 | 57 | 65 | N/A |
| 3/31/2021 | 698 | 47 | 64 | 65 | N/A |
| 12/31/2020 | 687 | 38 | 45 | 46 | N/A |
| 9/30/2020 | 689 | 35 | 52 | 52 | N/A |
| 6/30/2020 | 665 | 22 | 47 | 48 | N/A |
| 3/31/2020 | 630 | 18 | 7 | 8 | N/A |
| 12/31/2019 | 561 | 14 | 13 | 14 | N/A |
| 9/30/2019 | 488 | 4 | 3 | 4 | N/A |
| 6/30/2019 | 499 | 10 | -11 | -10 | N/A |
| 3/31/2019 | 492 | 9 | 16 | 17 | N/A |
| 12/31/2018 | 520 | 11 | 24 | 25 | N/A |
| 9/30/2018 | 506 | 28 | 46 | 47 | N/A |
| 6/30/2018 | 436 | 24 | 39 | 41 | N/A |
| 3/31/2018 | 395 | 24 | 33 | 35 | N/A |
| 12/31/2017 | 356 | 26 | N/A | 52 | N/A |
| 9/30/2017 | 336 | 13 | N/A | 44 | N/A |
| 6/30/2017 | 323 | 11 | N/A | 45 | N/A |
| 3/31/2017 | 317 | 12 | N/A | 47 | N/A |
| 12/31/2016 | 306 | 11 | N/A | 22 | N/A |
| 12/31/2015 | 313 | 13 | N/A | 32 | N/A |
| 12/31/2014 | 134 | -1 | N/A | 16 | N/A |
Analystenprognosen zum zukünftigen Wachstum
Einkommen vs. Sparrate: ASTHDas prognostizierte Gewinnwachstum (16.7% pro Jahr) liegt über der Sparquote (2.4%).
Ertrag vs. Markt: ASTHDie Erträge des Unternehmens (16.7% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (14.4% pro Jahr).
Hohe Wachstumserträge: ASTHDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.
Einnahmen vs. Markt: ASTHDie Einnahmen des Unternehmens (12.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (8.7% pro Jahr).
Hohe Wachstumseinnahmen: ASTHDie Einnahmen des Unternehmens (12.9% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.
Wachstumsprognosen für den Gewinn je Aktie
Künftige Eigenkapitalrendite
Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von ASTH in 3 Jahren voraussichtlich hoch sein wird